Advances in imaging techniques have allowed researchers to better understand these mechanisms, paving the way for potential clinical ... manifestations associated with systemic lupus erythematosus.
Systemic lupus erythematosus is a multisystem autoimmune disease with wide-ranging pleuropulmonary manifestations. Acute lupus pneumonitis is one of its uncommon complications. We report a 36-year-old ...
In this difficult clinical situation ... rituximab? SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences ...
Systemic lupus erythematosus (SLE) often presents with neuropsychiatric (NP) involvement, including cognitive impairment and depression. Past magnetic resonance imaging (MRI) research in SLE patients ...
SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life.
EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.
Your gut microbiome can trigger an immune response, leading to chronic systemic inflammation and lupus. Here are some tips to tame your immune system and improve brain function.
uhn.ca Objective To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European ... and regardless of their specific clinical or immunological ...
Systemic lupus erythematosus (SLE ... serious condition that occurs in 5-10% of SLE patients and can present with symptoms ranging from unexplained tachycardia to severe heart failure.
Imvotamab is under clinical development by IGM Biosciences and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a 73% ...
163.com Pulmonary arterial hypertension (PAH) is a severe complication of systemic lupus erythematosus (SLE), and SLE-PAH is the most common ... pulmonary thrombosis and lung diseases were excluded.4 ...